How transposable elements evade the host's genetic defenses
Mechanisms and evolutionary consequences of transposon strategies to counteract host silencing
This study looks at how certain genetic elements in fruit flies can avoid being shut down by the fly's own defenses, helping us learn more about how genes work and evolve over time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers, the State Univ of N.j. NIH-funded |
| Lab location | 1 site (Piscataway, United States) |
| Project ID | NIH-10754506 on NIH RePORTER |
What this research studies
This research investigates how transposable elements (TEs), which can cause mutations in the host genome, develop strategies to evade the host's defense mechanisms. By studying the fruit fly Drosophila melanogaster, the researchers aim to uncover the evolutionary dynamics between TEs and their hosts. They will focus on a specific TE that uses its own small RNA molecules to suppress the host's silencing factors, providing insights into this complex interaction. The findings could enhance our understanding of genetic regulation and evolution.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with genetic disorders linked to transposable elements or those interested in genetic research advancements.
Not a fit: Patients with conditions unrelated to genetic mutations or transposable elements may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding genetic regulation, which may have implications for treating genetic disorders.
How similar studies have performed: While the specific mechanisms of TE evasion are not fully understood, similar research has shown promising results in understanding genetic interactions and evolutionary biology.
Where this research is happening
Piscataway, United States
- Rutgers, the State Univ of N.j. — Piscataway, United States (Active)
Researchers
- Principal investigator: Ellison, Christopher Eugene — Rutgers, the State Univ of N.j.
- Study coordinator: Ellison, Christopher Eugene
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.